Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PKUMDL-WQ-2201

😃Good
Catalog No. T28425Cas No. 592474-91-4
Alias PKUMDL-WQ2201

PKUMDL-WQ-2201 is a PHGDH non-NAD⁺-competing allosteric inhibitor with micromolar potency against wild-type and mutant PHGDH enzymes, effectively suppressing de novo serine biosynthesis in cancer cells and reducing tumor growth, PKUMDL-WQ-2201 provide a metabolic intervention strategy for studying serine-dependent tumor metabolism.

PKUMDL-WQ-2201

PKUMDL-WQ-2201

😃Good
Catalog No. T28425Alias PKUMDL-WQ2201Cas No. 592474-91-4
PKUMDL-WQ-2201 is a PHGDH non-NAD⁺-competing allosteric inhibitor with micromolar potency against wild-type and mutant PHGDH enzymes, effectively suppressing de novo serine biosynthesis in cancer cells and reducing tumor growth, PKUMDL-WQ-2201 provide a metabolic intervention strategy for studying serine-dependent tumor metabolism.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$825 days5 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
PKUMDL-WQ-2201 is a PHGDH non-NAD⁺-competing allosteric inhibitor with micromolar potency against wild-type and mutant PHGDH enzymes, effectively suppressing de novo serine biosynthesis in cancer cells and reducing tumor growth, PKUMDL-WQ-2201 provide a metabolic intervention strategy for studying serine-dependent tumor metabolism.
In vitro
In PHGDH-amplified breast cancer cell lines such as MDA-MB-468, treatment with PKUMDL-WQ-2201 effectively inhibited serine synthesis and suppressed cell proliferation with GI50 values ranging from 6 to 20 μM. This antiproliferative effect was accompanied by the induction of apoptosis in the treated cells [1].
SynonymsPKUMDL-WQ2201
Chemical Properties
Molecular Weight351.81
FormulaC15H14ClN3O3S
Cas No.592474-91-4
SmilesO=C(O)C=1C=CC(=CC1Cl)C=2OC(C=NNC(=S)NCC)=CC2
Relative Density.1.41 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (227.4 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8424 mL14.2122 mL28.4244 mL142.1222 mL
5 mM0.5685 mL2.8424 mL5.6849 mL28.4244 mL
10 mM0.2842 mL1.4212 mL2.8424 mL14.2122 mL
20 mM0.1421 mL0.7106 mL1.4212 mL7.1061 mL
50 mM0.0568 mL0.2842 mL0.5685 mL2.8424 mL
100 mM0.0284 mL0.1421 mL0.2842 mL1.4212 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PKUMDL-WQ-2201 | purchase PKUMDL-WQ-2201 | PKUMDL-WQ-2201 cost | order PKUMDL-WQ-2201 | PKUMDL-WQ-2201 chemical structure | PKUMDL-WQ-2201 in vitro | PKUMDL-WQ-2201 formula | PKUMDL-WQ-2201 molecular weight